histidine has been researched along with Angiogenesis, Pathologic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CW; Cohn, DE; Cosgrove, CM; Dama, P; Gillespie, JL; Goodfellow, PJ; Mutch, DG; O'Hern, MJ; Rush, CM; Selvendiran, K; Shakya, R; Smith, B; Song, JW; Stein, ME; Walker, CJ; Zingarelli, RA | 1 |
| Chen, SS; Mi, J; Wang, JH | 1 |
| Ambulos, N; Cambell, P; Goldgeier, L; Leng, Q; Mixson, AJ; Zhu, J | 1 |
| Lowther, WT; Matthews, BW; McMillen, DA; Orville, AM | 1 |
| Chang, YH; Griffith, EC; Liu, JO; Niwayama, S; Ramsay, CA; Su, Z | 1 |
| Shapiro, R; Vallee, BL | 1 |
1 review(s) available for histidine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Histidine-lysine peptides as carriers of nucleic acids.
Topics: Angiostatic Proteins; Animals; DNA; Gene Expression Regulation, Neoplastic; Genetic Therapy; Histidine; Humans; Lysine; Neoplasms; Neovascularization, Pathologic; Nucleic Acid Conformation; Peptides; Protein Conformation; RNA Interference; RNA, Small Interfering; Transfection; Tumor Burden | 2007 |
5 other study(ies) available for histidine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional Characterization.
Topics: Aged; Aged, 80 and over; Amino Acid Substitution; Animals; Animals, Outbred Strains; Arginine; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Carcinoma, Endometrioid; Cells, Cultured; Codon, Nonsense; Endometrial Neoplasms; Female; Genetic Association Studies; Genetic Predisposition to Disease; HEK293 Cells; Histidine; Humans; Mice; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Neovascularization, Pathologic | 2018 |
[Effect of soluble vascular endothelial growth factor (VEGF) receptor gene (sflt-1) and antisense VEGF nucleotide on neovascularization].
Topics: Adenoviridae; Animals; Cell Division; Cells, Cultured; Chick Embryo; Endothelium, Vascular; Gene Expression; Genetic Vectors; Histidine; Humans; Mice; Neovascularization, Pathologic; Recombinant Fusion Proteins; RNA, Antisense; Solubility; Tumor Cells, Cultured; Vascular Endothelial Growth Factor Receptor-1 | 2002 |
The anti-angiogenic agent fumagillin covalently modifies a conserved active-site histidine in the Escherichia coli methionine aminopeptidase.
Topics: Aminopeptidases; Base Sequence; Binding Sites; Cyclohexanes; DNA Primers; Escherichia coli; Fatty Acids, Unsaturated; Histidine; Mass Spectrometry; Methionyl Aminopeptidases; Neovascularization, Pathologic; Protein Binding; Recombinant Proteins; Sesquiterpenes | 1998 |
Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.
Topics: Amino Acid Sequence; Aminopeptidases; Animals; Anti-Bacterial Agents; Catalytic Domain; Cell Division; Cell Line; Cyclohexanes; Cysteine; Endothelium, Vascular; Fatty Acids, Unsaturated; Histidine; Humans; Metalloendopeptidases; Mutagenesis, Site-Directed; Neovascularization, Pathologic; Recombinant Proteins; Sesquiterpenes; Spodoptera; Transfection | 1998 |
Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis.
Topics: Alanine; Amino Acids; Angiogenesis Inducing Agents; Animals; Chick Embryo; Chromatography, High Pressure Liquid; Dinucleoside Phosphates; DNA; Escherichia coli; Gene Expression Regulation; Growth Substances; Histidine; Humans; Kinetics; Mutation; Neovascularization, Pathologic; Proteins; Ribonuclease, Pancreatic; Ribonucleases; RNA, Transfer, His | 1989 |